Aperam S.A.
APEMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $2 | $4 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $2 | $3 | $3 | $4 |
| Revenue | $6 | $7 | $8 | $5 |
| % Growth | -5.1% | -19.2% | 59.9% | – |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | 7.2% | 5% | 14.5% | 24.2% |
| EBITDA | $0 | $0 | $1 | $1 |
| % Margin | 5.7% | 5.5% | 11.7% | 23.5% |
| Net Income | $0 | $0 | $1 | $1 |
| % Margin | 3.7% | 3.1% | 7.7% | 19% |
| EPS Diluted | 3.17 | 2.79 | 8.29 | 12.17 |
| % Growth | 13.6% | -66.3% | -31.9% | – |
| Operating Cash Flow | $0 | $0 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |